US EditionNew pill that 'slows down Alzheimer's' being considered for use by NHS
- A new pill called Hydromethylthionine is being considered for use in the NHS to slow down Alzheimer's disease.
- The drug could slow cognitive decline and brain atrophy in mild-to-moderate Alzheimer's disease.
- If approved, it would be the biggest step forward in treating NHS dementia patients in decades.
- Professor Alistair Burns called the trial results 'great news for people with Alzheimer’s disease, their families, and carers.
Insights by Ground AI
Does this summary seem wrong?
14 Articles
14 Articles
The drugs will be available in the EU from next year. The earlier in the course of the disease they are administered, the more effective they are.
·Zürich, Switzerland
Read Full Article
After years of waiting, the news came: the EU's Medicines Authority says yes to the drug lekanemab against Alzheimer's. But the question is which patients can be treated, and when - and if it will be introduced at all in the country's regions.
·Stockholm, Sweden
Read Full ArticleCoverage Details
Total News Sources14
Leaning Left0Leaning Right5Center1Last UpdatedBias Distribution83% Right
Bias Distribution
- 83% of the sources lean Right
83% Right
C 17%
R 83%
Factuality
To view factuality data please Upgrade to Premium
